Huibiao Quan

Dr. Huibiao Quan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TLTangying Li
Tangying Li
HQHuibiao Quan
Huibiao Quan
HZHuachuan Zhang
Huachuan Zhang
LLLeweihua Lin
Leweihua Lin
LLLu Lin
Lu Lin
KCKaining Chen
Kaining Chen
Men and women are sexually dimorphic but whether common anthropometric and biochemical parameters predict type 2 diabetes (T2D) in different ways has not been well studied. Here we recruit 1579 participants in Hainan Province, China, and group them by sex. We compared the prediction power of common parameters of T2D in two sexes by association, regression, and Receiver Operating Characteristic (ROC) analysis. HbA1c is associated with FPG stronger in women than in men and the regression coefficient is higher, consistent with higher prediction power for T2D. Age, waist circumference, BMI, systolic and diastolic blood pressure, triglyceride levels, total cholesterol, LDL, HDL, fasting insulin, and proinsulin levels all predict T2D better in women. Except for diastolic blood pressure, all parameters associate or tend to associate with FPG stronger in women than in men. Except for diastolic blood pressure and fasting proinsulin, all parameters associate or tend to associate with HbA1c stronger in women than in men. Except for fasting proinsulin and HDL, the regression coefficients of all parameters with FPG and HbA1c were higher in women than in men. Together, by the above anthropometric and biochemical measures, T2D is more readily predicted in women than men, suggesting the importance of sex-based subgroup analysis in T2D research.

18 March 2020 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
JZJinjia Zhang
Jinjia Zhang
YGYiyang Gao
Yiyang Gao
YLYONGZE LI
YONGZE LI
DTDi Teng
Di Teng
YXYuanming Xue
Yuanming Xue
JLJing Li
Jing Li
Purpose: The expressions of antibodies against thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) are very common in the sera of patients with autoimmune thyroid diseases (AITD). The relationship between thyroid autoantibodies and the occurrence of glucose and lipid metabolic disorders remains unclear. This study was performed to investigate the correlation between the presence of serum TPOAb/TgAb and those metabolic disorders in euthyroid general population. Methods: The data of this study were derived from the Thyroid Disease, Iodine status, and Diabetes National epidemiological (TIDE) survey from all 31 provinces of mainland China. A total of 17,964 euthyroid subjects including 5,802 males (4,000 with TPOAb−TgAb− and 1,802 with TPOAb+/TgAb+) and 12,162 females (8,000 with TPOAb−TgAb− and 4,162 with TPOAb+/TgAb+) were enrolled in this study. The blood glucose and lipid levels were compared between individuals with TPOAb−TgAb− and those with TPOAb+TgAb−, TPOAb−TgAb+, TPOAb+TgAb+. Results: Both fasting blood glucose (FBG) concentration and the proportion of individuals with impaired FBG (IFG) showed the decreased trends in TPOAb−TgAb+ males as compared with TPOAb−TgAb− men. There were significantly lower FBG and higher HDL-C levels as well as tendencies toward decreased incidences of IGT and hypertriglyceridemia in TPOAb−TgAb+ females when compared with TPOAb−TgAb− women. Binary logistic regression analysis further showed that serum TgAb single positivity in males was an independent protective factor for IFG with an OR of 0.691 (95% CI, 0.503–0.949). For females, serum TgAb single positivity was an independent protective factor for hypertriglyceridemia with an OR of 0.859 (95% CI, 0.748–0.987). Trend test showed that with the increase of serum TgAb level, there were significant decreases in the prevalence of IFG among the men with TSH ≤ 2.5 mIU/L and that of hypertriglyceridemia in the women, especially among non-obese females. Conclusion: Serum TgAb single positivity may imply a reduced risk of IFG in euthyroid men and that of hypertriglyceridemia in euthyroid women. The mechanisms for the independent protective roles of TgAb await further investigation.

27 September 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DLDanhong Lin
Danhong Lin
JYJingwen Yu
Jingwen Yu
LLLeweihua Lin
Leweihua Lin
QOQianying Ou
Qianying Ou
HQHuibiao Quan
Huibiao Quan
Lack of efficient insulin secretion from the pancreas can lead to impaired glucose tolerance (IGT), prediabetes, and diabetes. We have previously identified two IGT-associated single nucleotide polymorphisms (SNPs) rs62212118 and rs13052524 located at two overlapping genes: MRPS6 and SLC5A3. In this study, we show that MRPS6 but not SLC5A3 regulates glucose-stimulated insulin secretion (GSIS) in primary human β-cell and a mouse pancreatic insulinoma β-cell line. Data mining and biochemical studies reveal that MRPS6 is positively regulated by the mitochondrial unfolded protein response (UPRmt), but feedback inhibits UPRmt. Disruption of such feedback by MRPS6 knockdown causes UPRmt hyperactivation in high glucose conditions, hence elevated ROS levels, increased apoptosis, and impaired GSIS. Conversely, MRPS6 overexpression reduces UPRmt, mitigates high glucose-induced ROS levels and apoptosis, and enhances GSIS in an ATF5-dependent manner. Consistently, UPRmt up-regulation or down-regulation by modulating ATF5 expression is sufficient to decrease or increase GSIS. The negative role of UPRmt in GSIS is further supported by analysis of public transcriptomic data from murine islets. In all, our studies identify MRPS6 and UPRmt as novel modulators of GSIS and apoptosis in β-cells, contributing to our understanding of the molecular and cellular mechanisms of IGT, prediabetes, and diabetes.

9 July 2022 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
TFTuanyu Fang
Tuanyu Fang
LLLeweihua Lin
Leweihua Lin
QOQianying Ou
Qianying Ou
LLLu Lin
Lu Lin
HZHuachuan Zhang
Huachuan Zhang
YHYangli He
Yangli He
Background. In recent years, the incidence of thyroid diseases has increased significantly, which has seriously affected people's work and life. The purpose of this study was to explore the epidemiological characteristics of thyroid diseases and autoantibodies. Method. According to the principle of overall sampling, resident residents 18 years and who will not move within 5 years are randomly selected. A total of 2136 eligible individuals were divided into case and control groups according to whether they have thyroid disease. Finally, the impact of potential risk factors on thyroid diseases was evaluated. Results. The overall prevalence of thyroid disease was 58.3, and there was a significant difference in the prevalence of thyroid disease between women and men (p=0.004). Except for the age group 70 years, with the increase in age, the prevalence gradually increased (p<0.05). Participants with positive thyroid autoantibodies (TPOAb or TgAb) had a higher prevalence than participants with negative autoantibodies. The positive rate of autoantibodies in women was higher than that in men (p<0.05). UIC (p=0.004) and free thyroid hormone (FT4) (p=0.001) levels of men were higher than those of women, and the TSH level of women was higher than that of men (p=0.002). The regression analysis showed that women, older age, and family history of thyroid disease were independent risk factors for thyroid disease. Conclusion. The prevalence of thyroid diseases in Hainan was high. Women are more susceptible to thyroid disease than men, and the prevalence increased with age.

2 February 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
ZGZhenshu Gao
Zhenshu Gao
CPChangchun Pu
Changchun Pu
LLLeweihua Lin
Leweihua Lin
QOQianying Ou
Qianying Ou
HQHuibiao Quan
Huibiao Quan
Background: Dyslipidemia is highly prevalent among individuals with prediabetes, further exacerbating their cardiovascular risk. However, the genetic determinants underlying diabetic dyslipidemia in Southern Han Chinese remain largely unexplored.Methods: We performed a genome-wide association study (GWAS) of blood lipid traits in 451 Southern Han Chinese adults with prediabetes. Fasting plasma lipids, including triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were assayed. Genotyping was conducted using the Precision Medicine Diversity Array and Gene Titan platform, followed by genotype imputation using IMPUTE2 with the 1000 Genomes Project (Phase 3, Southern Han Chinese) as reference. Single nucleotide polymorphisms (SNPs) associated with lipid levels were identified using mixed linear regression, with adjustment for covariates.Results: We identified 58, 215, 74 and 81 novel SNPs associated with TG, TC, HDL-C and LDL-C levels, respectively (P < 5×10-5). Several implicated loci were located in or near genes involved in lipid metabolism, including SRD5A2, PCSK7, PITPNC1, IRX3, BPI, and LBP. Pathway enrichment analysis highlighted lipid metabolism and insulin secretion.Conclusion: This first GWAS of dyslipidemia in Southern Han Chinese with prediabetes identified novel genetic variants associated with lipid traits. Our findings provide new insights into genetic mechanisms underlying heightened cardiovascular risk in the prediabetic stage. Functional characterization of implicated loci is warranted.

30 October 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
DLDexia Li
Dexia Li
LLLeweihua Lin
Leweihua Lin
ZGZhenshu Gao
Zhenshu Gao
DLDanhong Lin
Danhong Lin
JZJiahuan Zhang
Jiahuan Zhang
HQHuibiao Quan
Huibiao Quan
Pregnancy-associated fulminant type 1 diabetes (FT1DM) is characterized by abrupt loss of endogenous insulin secretion and rapid progression to diabetic ketoacidosis (DKA). Recognition may be particularly challenging when FT1DM develops in a pregnancy already treated with insulin for gestational diabetes mellitus (GDM), because sudden glycemic deterioration may be attributed to increasing gestational insulin resistance, inadequate insulin dosing, or treatment interruption. We report a 24-year-old woman with insulin-treated GDM who developed dizziness, nausea, and vomiting at 33 weeks of gestation after one scheduled basal insulin dose was omitted. At a referring hospital, plasma glucose was 19.14 mmol/L (345 mg/dL) and urinary ketones were 3 +. Fetal cardiac activity was reportedly present initially but was absent the following day, when intrauterine fetal demise was confirmed. After transfer, plasma glucose was 20.77 mmol/L (374 mg/dL), beta-hydroxybutyrate 6.63 mmol/L (69.0 mg/dL), arterial pH was 7.235, and bicarbonate was 6.00 mmol/L (6.00 mEq/L), confirming persistent severe DKA; glycated hemoglobin was 6.1% (43 mmol/mol). Fasting and stimulated C-peptide concentrations remained profoundly reduced after metabolic stabilization, supporting the diagnosis of pregnancy-associated FT1DM. DKA improved with intravenous fluids, insulin, electrolyte replacement, and close biochemical monitoring, after which labor was induced and a stillborn female fetus was delivered. Repeated glucose and C-peptide measurements during long-term follow-up demonstrated persistent near-complete endogenous insulin deficiency. This case highlights the risk of diagnostic anchoring in insulin-treated GDM. Abrupt gastrointestinal symptoms or unexpected glycemic deterioration should prompt immediate assessment for ketosis and acidosis rather than being attributed solely to gestational insulin resistance or an isolated interruption of insulin treatment.